Las Vegas Snds SEC Filings

Las Vegas Sands Corp. insiders Miriam Adelson, Irwin Chafetz and related Adelson family trusts filed an amended beneficial ownership report. Together they may be deemed to beneficially own 386,724,043 shares of common stock, or 57.4% of the company’s 672,851,932 shares outstanding as of December 16, 2025.

Dr. Miriam Adelson is reported to beneficially own 341,442,911 shares, about 50.7% of the outstanding stock, primarily through family trusts and options to purchase 561,578 shares. Two key Adelson family trusts each directly hold about 87.7 million shares, or 13.0% of the outstanding stock. The amendment notes that the group’s ownership percentages have risen passively as the company repurchased its own shares, and also reflects recent insider trades: Irwin Chafetz sold 30,000 shares at a weighted average price of $69.76, while The Miriam Adelson Trust exercised options on 77,991 shares at $40.87 and sold the same number at a weighted average price of $67.56.

Las Vegas Sands Corp. director Miriam Adelson reported several insider transactions dated December 16, 2025, involving common stock held through Adelson family trusts. Through Trust K, she reported exercising stock options and related trades in the company’s shares.

Trust K acquired 77,991 shares of common stock at an exercise price of $40.87 per share and then sold 77,991 shares at a weighted average price of $67.56, with individual sale prices ranging from $67.49 to $67.72. Separately, Trust OO transferred 2,316,840 shares for no consideration among Adelson family members or their trusts. After these transactions, Trust K reported indirect beneficial ownership of 23,333,441 shares, while additional family members or trusts not otherwise listed held 317,547,892 shares indirectly attributed to Adelson. The options exercised were fully vested and had been scheduled to expire on January 25, 2026.

Las Vegas Sands Corp. reported insider transactions by Chairman and CEO Robert Goldstein. On December 12, 2025, he exercised options to acquire 15,489 common shares at $50.33 per share and sold the same number at a weighted average price of $66.24. On December 15, 2025, he exercised options to acquire 734,511 shares at $50.33 and sold 732,186 shares at a weighted average price of $66.8, followed by an additional sale of 2,325 shares at a weighted average price of $67.28, leaving him with no directly held common shares after these transactions. Beneficial ownership includes 129,005 shares held indirectly through The Robert and Sheryl Goldstein Trust, as well as vested options to purchase 1,250,000 shares and 403,800 unvested restricted stock units.

A holder of the issuer’s common stock filed a notice of proposed sale under Rule 144 covering 77991 common shares. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of 5268836.24 and an approximate sale date of 12/16/2025.

The filing states that these common shares were acquired from the issuer via an option granted on 01/26/2016 and paid for in cash on 12/16/2025, in the same amount of 77991 shares. It also notes that the issuer has 676134487 shares outstanding, providing context for the size of the planned sale.

Las Vegas Sands shareholder Robert G. Goldstein has filed a notice to sell 1,500,000 shares of common stock under Rule 144 through Goldman Sachs & Co. LLC.

The planned sale on the form has an aggregate market value of $100,485,000, with 676,134,487 shares of common stock stated as outstanding and the stock listed on the NYSE.

The shares to be sold were acquired on 12/15/2025 as compensation via stock options, using a cashless exercise and same-day sale structure, and the notice also lists several recent sales over the prior three months, including 700,000 shares on 10/29/2025 for gross proceeds of 41,195,840.

Las Vegas Sands insider plans another stock sale under Rule 144. Robert G. Goldstein has filed to sell 500,000 shares of Las Vegas Sands common stock through Goldman Sachs & Co. LLC on or about 12/12/2025 on the NYSE. The shares have an aggregate market value of 32,620,000, compared with 676,134,487 shares outstanding.

The shares were acquired on 12/12/2025 as compensation via stock options, with a cashless exercise and same-day sale structure. Over the past three months, Goldstein has already sold multiple large blocks of common stock, including 700,000 shares on 10/29/2025 and 400,000 shares on 10/31/2025, each with disclosed gross proceeds.

Las Vegas Sands Corp. Chairman and CEO Robert Goldstein reported exercising and selling company stock. On December 10, 2025, he exercised options for 17,095 shares of common stock at an exercise price of $50.33 per share and sold the same number of shares at a weighted average price of $67.03, with individual sale prices ranging from $67.00 to $67.15.

On December 11, 2025, he exercised options for an additional 382,905 shares at $50.33 and sold 382,905 shares in total at weighted average prices of $66.39 and $67.00, with individual trades between $66.00 and $66.99. After these transactions, he reported no directly held common stock and 129,005 shares held indirectly through The Robert and Sheryl Goldstein Trust. He continues to hold options to purchase 2,000,000 shares that are vested and 403,800 unvested restricted stock units.

Las Vegas Sands Corp. insider Patrick Dumont, the company’s President & COO and a director, reported option exercises and share sales. On December 3, 2025, he exercised options to acquire 135,603 shares of common stock at an exercise price of $52.53 per share. That same day he sold 81,893 shares at a weighted average price of $67.66 and 53,710 shares at a weighted average price of $68.43, for total reported sales matching the shares acquired. Following these transactions, he directly owned 446,608 shares of common stock. He also holds vested options to purchase 1,561,740 shares and 207,076 unvested restricted stock units.

Las Vegas Sands Corp. Chairman and CEO Robert Goldstein reported an option exercise and share sale. On December 1, 2025, he exercised options to buy 100,000 shares of common stock at an exercise price of $50.33 per share, increasing his direct holdings by that amount.

On the same day, he sold 100,000 shares of common stock at a weighted average price of $70.17 per share, leaving him with no shares held directly and 129,005 shares held indirectly through The Robert and Sheryl Goldstein Trust. After these transactions, he continues to hold options to purchase 2,400,000 shares that are vested and 403,800 unvested restricted stock units, indicating a substantial remaining equity-based stake.